<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2025-15-38-45</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-4468</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Динамика постуральной неустойчивости  на фоне двусторонней глубокой стимуляции субталамического ядра головного мозга у больных с болезнью Паркинсона</article-title><trans-title-group xml:lang="en"><trans-title>Dynamics of postural instability in Parkinson's disease patients undergoing bilateral subthalamic nucleus deep brain stimulation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0056-2842</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Султанова</surname><given-names>С. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sultanova</surname><given-names>S. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Султанова Салихат Гитинмагомедовна, аспирант кафедры неврологии с курсом рефлексологии и мануальной терапии</p><p>Москва</p></bio><bio xml:lang="en"><p>Sultanova Salihat G., graduate student of the department of neurology with a course in reflexology and manual therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2168-2138</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федорова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федорова Наталия Владимировна, д.м.н., проф. кафедры неврологии с курсом рефлексологии и мануальной терапии</p><p>Москва</p></bio><bio xml:lang="en"><p>Fedorova Nataliya V., DM Sci (habil.), professor at Dept of Neurology with a Course in Reflexology and Manual Therapy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5569-6688</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Верюгина</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Verugina</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смоленцева Ирина Геннадьевна, д.м.н., проф. кафедры неврологии с курсом рефлексологии и мануальной терапии; начальник лечебно- реабилитационного центра</p><p>Москва</p></bio><bio xml:lang="en"><p>Verugina Nadezhda I., PhD Med, neurologist at Consultative and Diagnostic Center</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5569-6688</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смоленцева</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolentseva</surname><given-names>I. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смоленцева Ирина Геннадьевна, д.м.н., проф. кафедры неврологии с курсом рефлексологии и мануальной терапии; начальник лечебно- реабилитационного центра</p><p>Москва</p></bio><bio xml:lang="en"><p>Smolentseva Irina G., DM Sci (habil.), professor at Dept of Neurology with a Course in Reflexology and Manual Therapy; chief of the Medical and Rehabilitation Center</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6524-4490</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бриль</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bril</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бриль Екатерина Витальевна, к.м.н., доцент кафедры неврологии с курсом рефлексологии и мануальной терапии1, руководитель Федерального неврологического центра экстрапирамидных заболеваний и психического здоровья4. ORCID: 0000-0002-6524-4490</p><p>Москва</p></bio><bio xml:lang="en"><p>Bril Ekaterina V., PhD Med, assistant professor at Dept of Neurology with a Course in Reflexology and Manual Therapy; chief of the Federal Neurological Center for Extrapyramidal Diseases and Mental Health</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6412-8148</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гамалея</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gamaleya</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гамалея Анна Александровна, врач-невролог научно-консультативного отделения</p><p>Москва</p></bio><bio xml:lang="en"><p>Gamaleya Anna A., neurologist at Scientific and Consultative Dept</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2120-0146</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Томский</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tomskiy</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Томский Алексей Алексеевич, к.м.н., руководитель группы функциональной нейрохирургии</p><p>Москва</p></bio><bio xml:lang="en"><p>Tomskiy Aleksej A., PhD Med, chief of Functional Neurosurgery Group</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ города Москвы «Московский многопрофильный научно-клинический центр имени С. П. Боткина Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S. P. Botkin Moscow Multidisciplinary Research and Clinical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ФГБУ «Клиническая больница» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education; Central Clinical Hospital with Polyclinic of Medical Center the Administrative</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ГНЦ «Федеральный медико-биологический центр им. А. И. Бурназяна» Федерального медико-биологического агентства России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuous Professional Education; Federal Medical and Biological Agency A. I. Burnazyan Federal Medical and Biophysical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАУ «Национальный медицинский исследовательский центр нейрохирургии им. ак. Н. Н. Бурденко» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N. N. Burdenko National Scientific and Practical Center for Neurosurgery</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>07</month><year>2025</year></pub-date><volume>0</volume><issue>15</issue><issue-title>«Неврология и психиатрия» (2)</issue-title><fpage>38</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Султанова С.Г., Федорова Н.В., Верюгина Н.И., Смоленцева И.Г., Бриль Е.В., Гамалея А.А., Томский А.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Султанова С.Г., Федорова Н.В., Верюгина Н.И., Смоленцева И.Г., Бриль Е.В., Гамалея А.А., Томский А.А.</copyright-holder><copyright-holder xml:lang="en">Sultanova S.G., Fedorova N.V., Verugina N.I., Smolentseva I.G., Bril E.V., Gamaleya A.A., Tomskiy A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/4468">https://www.med-alphabet.com/jour/article/view/4468</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Оценка динамики постуральной устойчивости у больных с развернутыми стадиями болезни Паркинсона (БП) на фоне двусторонней хронической глубокой стимуляции субталамического ядра (ГС СТЯ) на протяжении 12 месяцев постоперационного наблюдения.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование включены 80 пациентов с БП, из них 40 пациентов основной группы, которым проведена ГС СТЯ, и 40 пациентов группы сравнения, получающих только лекарственную терапию. Пациентам основной группы проводилось клинико- неврологическое исследование за неделю перед операцией, а также через 3, 6 и 12 месяцев после операции; пациентам группы сравнения – в начале исследования и через 12 месяцев наблюдения.</p></sec><sec><title>Результаты</title><p>Результаты. ГС СТЯ у пациентов основной группы привела к значительному улучшению двигательных показателей по шкале UPDRS, уменьшению выраженности постуральной неустойчивости в период «выключения», улучшению уверенности в равновесии по шкале АВС на протяжении 12 месяцев наблюдения (р&lt;0,05). В период «включения» ГС СТЯ не оказала значимого влияния на показатели равновесия. У пациентов группы сравнения через 12 месяцев наблюдения отмечалось достоверное нарастание неустойчивости, гипокинезии, застываний, нарушений ходьбы и двигательного дефицита по шкале UPDRS-III. Через 12 месяцев ГС СТЯ способствовала снижению суточной дозы леводопы у пациентов основной группы на 73,43 % и уменьшению выраженности моторных флуктуаций и лекарственных дискинезий по шкале UPDRS-IV более чем на 70 %, в группе сравнения доза препаратов увеличилась, а баллы по шкале UPDRS-IV ухудшились. На фоне глубокой стимуляции мозга (ГСМ) отмечался регресс флуктуаций постуральной неустойчивости в периоды «включения» и «выключения» на фоне приема леводопы.</p></sec><sec><title>Заключение</title><p>Заключение. Через 12 месяцев на фоне ГС СТЯ у пациентов с БП выявлено достоверное уменьшение выраженности постуральной неустойчивости в периоде «выключения» и отсутствие эффекта на постуральные функции в периоде «включения». Выявлена стабилизация постуральных функций на удовлетворительном уровне, без колебания в зависимости от периодов «включения» и «выключения».</p></sec></abstract><trans-abstract xml:lang="en"><p>Introduction. Subthalamic nucleus deep brain stimulation (STN DBS) is a highly effective method of neurosurgical treatment of Parkinson’s disease (PD), which can significantly reduce the motor symptoms of the disease (rigidity, tremor, hypokinesia). However, the effect of STN DBS postural stability remains contradictory.The purpose of the study. Evaluation of the dynamics of postural instability in advanced PD patients undergoing bilateral STN DBS during 12 months of postoperative observation.Materials and methods. The study included 80 patients with PD: 40 patients in the main group who undergoing STN DBS, and 40 patients in the control group who received only drug therapy. Patients in the main group underwent clinical neurological examination a week before surgery, as well as 3, 6 and 12 months after surgery; patients in the control group – at the beginning of the study and after 12 months of observation.Results. SN DBS in patients of the main group led to a significant improvement in motor performance on the UPDRS-III scale, a decrease in the severity of postural instability during the «OFF» period, and improved confidence in balance on the ABC scale throughout the 12 months of observation (p&lt;0,05). During the «ON» period, the STN DBS did not have a significant effect on the postural instability. After 12 months of follow- up, patients in the control group showed a significant increase in instability, hypokinesia, freezing, walking disorders, and motor deficits on the UPDRS-III scale. After 12 months, SN DBS contributed to a 73,43 % reduction in the daily dose of levodopa in patients in the main group and a decrease in the severity of motor fluctuations and dyskinesias on the UPDRS-IV scale by more than 70 %, while in the comparison group the dose of levodopa increased and the UPDRS-IV scores worsened. In patients with STN DBS, there was a regression of fluctuations in postural instability during periods of «ON» and «OFF» while taking levodopa.Conclusions. After 12 months, patients undergoing bilateral STN DBS showed a significant decrease in the severity of postural instability during the «OFF» period and no effect on postural functions during the «ON» period. The stabilization of postural functions was revealed at a sufficient level, without fluctuation depending on the «ON» and «OFF» periods.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона</kwd><kwd>постуральная устойчивость</kwd><kwd>равновесие</kwd><kwd>глубокая стимуляция мозга</kwd><kwd>субталамическое ядро</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Parkinson’s disease</kwd><kwd>gait</kwd><kwd>postural stability</kwd><kwd>balance</kwd><kwd>deep brain stimulation</kwd><kwd>subthalamic nucleus</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tysnes O. B., Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017; (124): 901–905. https://doi.org/10.1007/s00702-017-1686-y</mixed-citation><mixed-citation xml:lang="en">Tysnes O. B., Storstein A. Epidemiology of Parkinson’s disease. J Neural Transm. 2017; (124): 901–905. https://doi.org/10.1007/s00702-017-1686-y</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Левин О. С., Федорова Н. В., Шток В. Н. Дифференциальная диагностика паркинсонизма. Журнал неврологии и психиатрии имени С. С. Корсакова. 2003; 103(2): 54–60.</mixed-citation><mixed-citation xml:lang="en">Левин О. С., Федорова Н. В., Шток В. Н. Дифференциальная диагностика паркинсонизма. Журнал неврологии и психиатрии имени С. С. Корсакова. 2003; 103(2): 54–60.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Levin O. S., Fedorova N. V., Shtok V. N. Differential diagnosis of parkinsonism. Zh Nevrol Psikhiatr Im S. S. Korsakova. 2003; 103(2): 54–60. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Levin O. S., Fedorova N. V., Shtok V. N. Differential diagnosis of parkinsonism. Zh Nevrol Psikhiatr Im S. S. Korsakova. 2003; 103(2): 54–60. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бриль Е. В., Томский A. A., Гамалея А. А. и соавт. Сравнительное исследование эффективности нейрохирургического лечения (электростимуляция субталамического ядра) и медикаментозной терапии у больных на развернутой стадии болезни Паркинсона. Журнал неврологии и психиатрии им. С. С. Корсакова. 2014; 114 (6–2): 55–61.</mixed-citation><mixed-citation xml:lang="en">Бриль Е. В., Томский A. A., Гамалея А. А. и соавт. Сравнительное исследование эффективности нейрохирургического лечения (электростимуляция субталамического ядра) и медикаментозной терапии у больных на развернутой стадии болезни Паркинсона. Журнал неврологии и психиатрии им. С. С. Корсакова. 2014; 114 (6–2): 55–61.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bril E. V., Tomskiy A. A., Gamaleya A. A., Shabalov V. A. A comparative study of the efficacy of deep brain stimulation of the subthalamic nucleus and pharmacological treatment in advanced Parkinson’s disease. Zhurnal Nevrologii i Psikhiatrii im. S. S. Korsakova. 2014; 114 (6–2): 55–61. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Bril E. V., Tomskiy A. A., Gamaleya A. A., Shabalov V. A. A comparative study of the efficacy of deep brain stimulation of the subthalamic nucleus and pharmacological treatment in advanced Parkinson’s disease. Zhurnal Nevrologii i Psikhiatrii im. S. S. Korsakova. 2014; 114 (6–2): 55–61. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Левин О. С., Артемьев Д. В., Бриль Е. В. и соавт. Болезнь Паркинсона: современные подходы к диагностике и лечению. Практическая медицина. 2017; 102 (1): 45–51.</mixed-citation><mixed-citation xml:lang="en">Левин О. С., Артемьев Д. В., Бриль Е. В. и соавт. Болезнь Паркинсона: современные подходы к диагностике и лечению. Практическая медицина. 2017; 102 (1): 45–51.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Levin O. S., Artemyev D. V., Bril E. V. et al. Parkinson’s disease: modern approaches to diagnosis and treatment. Practical medicine. 2017; 102 (1): 45–51. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Levin O. S., Artemyev D. V., Bril E. V. et al. Parkinson’s disease: modern approaches to diagnosis and treatment. Practical medicine. 2017; 102 (1): 45–51. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Скрипкина Н. А., Левин О. С. Нарушения ходьбы при болезни Паркинсона. Журнал неврологии и психиатрии им. C. C. Корсакова. 2015; 115 (6–2): 54–60. https://doi.org/10.17116/jnevro20151156254–60</mixed-citation><mixed-citation xml:lang="en">Скрипкина Н. А., Левин О. С. Нарушения ходьбы при болезни Паркинсона. Журнал неврологии и психиатрии им. C. C. Корсакова. 2015; 115 (6–2): 54–60. https://doi.org/10.17116/jnevro20151156254–60</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Skripkina N. A., Levin O. S. Gait disorders in Parkinson’s disease. Zh Nevrol Psikhiatr Im S. S. Korsakova. 2015; 115 (6–2): 54–60. (In Russ.). https://doi.org/10.17116/jnevro20151156254–60</mixed-citation><mixed-citation xml:lang="en">Skripkina N. A., Levin O. S. Gait disorders in Parkinson’s disease. Zh Nevrol Psikhiatr Im S. S. Korsakova. 2015; 115 (6–2): 54–60. (In Russ.). https://doi.org/10.17116/jnevro20151156254–60</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Park J.-H., Kang Y.-J., Horak F. B. What is wrong with balance in Parkinson’s disease? J Mov Disord. 2015; (8): 109–114. https://doi.org/10.14802/jmd.15018.</mixed-citation><mixed-citation xml:lang="en">Park J.-H., Kang Y.-J., Horak F. B. What is wrong with balance in Parkinson’s disease? J Mov Disord. 2015; (8): 109–114. https://doi.org/10.14802/jmd.15018.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Левин О. С., Васенина Е. Е., Ганькина О. А. Индивидуализация лечения болезни Паркинсона: хронотерапевтические аспекты. Фармакология &amp; Фармакотерапия. 2020; (2); 39–45. https://doi.org/10.46393/2713-2129_2020_239-45</mixed-citation><mixed-citation xml:lang="en">Левин О. С., Васенина Е. Е., Ганькина О. А. Индивидуализация лечения болезни Паркинсона: хронотерапевтические аспекты. Фармакология &amp; Фармакотерапия. 2020; (2); 39–45. https://doi.org/10.46393/2713-2129_2020_239-45</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Levin O. S., Vasenina E. E., Gankina O. A. Individualization of the treatment of Parkinson’s disease: chronotherapeutic aspects. Pharmacology &amp; Pharmacotherapy. 2020; (2); 39–45. (In Russ.). https://doi.org/10.46393/2713-2129_2020_239-45</mixed-citation><mixed-citation xml:lang="en">Levin O. S., Vasenina E. E., Gankina O. A. Individualization of the treatment of Parkinson’s disease: chronotherapeutic aspects. Pharmacology &amp; Pharmacotherapy. 2020; (2); 39–45. (In Russ.). https://doi.org/10.46393/2713-2129_2020_239-45</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rogers G., Davies D., Pink J. et al. Parkinson’s disease: summary of updated NICE guidance. BMJ. 2017; (358): 1951–1956. https://doi.org/10.1136/bmj.j1951</mixed-citation><mixed-citation xml:lang="en">Rogers G., Davies D., Pink J. et al. Parkinson’s disease: summary of updated NICE guidance. BMJ. 2017; (358): 1951–1956. https://doi.org/10.1136/bmj.j1951</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Moro E., Lozano A. M., Pollak P. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010; 25 (5): 578–586. https://doi.org/10.1002/mds.22735</mixed-citation><mixed-citation xml:lang="en">Moro E., Lozano A. M., Pollak P. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010; 25 (5): 578–586. https://doi.org/10.1002/mds.22735</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Williams N. R., Foote K. D., Okun M. S. STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract. 2014; 1 (1): 24–35. https://doi.org/10.1002/mdc3.12004</mixed-citation><mixed-citation xml:lang="en">Williams N. R., Foote K. D., Okun M. S. STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice. Mov Disord Clin Pract. 2014; 1 (1): 24–35. https://doi.org/10.1002/mdc3.12004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Poston K. L., Eidelberg D. Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage. 2012; 62 (4): 2261–2270. https://doi.org/10.1016/j.neuroimage.2011.12.021</mixed-citation><mixed-citation xml:lang="en">Poston K. L., Eidelberg D. Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage. 2012; 62 (4): 2261–2270. https://doi.org/10.1016/j.neuroimage.2011.12.021</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Asanuma K., Tang C., Ma Y. et al. Network modulation in the treatment of Parkinson's disease. Brain. 2006;129 (10): 2667–2678. https://doi.org/10.1093/brain/awl162</mixed-citation><mixed-citation xml:lang="en">Asanuma K., Tang C., Ma Y. et al. Network modulation in the treatment of Parkinson's disease. Brain. 2006;129 (10): 2667–2678. https://doi.org/10.1093/brain/awl162</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">El Ouadih Y., Marques A., Pereira B. et al. Deep brain stimulation of the subthalamic nucleus in severe Parkinson's disease: relationships between dual-contact topographic setting and 1-year worsening of speech and gait. Acta Neurochir (Wien). 2023; 165 (12): 3927–3941. https://doi.org/10.1007/s00701-023-05843-9</mixed-citation><mixed-citation xml:lang="en">El Ouadih Y., Marques A., Pereira B. et al. Deep brain stimulation of the subthalamic nucleus in severe Parkinson's disease: relationships between dual-contact topographic setting and 1-year worsening of speech and gait. Acta Neurochir (Wien). 2023; 165 (12): 3927–3941. https://doi.org/10.1007/s00701-023-05843-9</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tomlinson C. L., Stowe R., Patel S. et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement disorders. 2010; 25 (15): 2649–2653. https://doi.org/10.1002/mds.23429</mixed-citation><mixed-citation xml:lang="en">Tomlinson C. L., Stowe R., Patel S. et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement disorders. 2010; 25 (15): 2649–2653. https://doi.org/10.1002/mds.23429</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Postuma R. B., Berg D., Stern M. et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement disorders. 2015; 30 (12): 1591–1601. https://doi.org/10.1002/mds.26424</mixed-citation><mixed-citation xml:lang="en">Postuma R. B., Berg D., Stern M. et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement disorders. 2015; 30 (12): 1591–1601. https://doi.org/10.1002/mds.26424</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">May D. S., van Dillen L. R., Earhart G. M. et al. Effects of Subthalamic Nucleus Deep Brain Stimulation and Levodopa on Balance in People with Parkinson's Disease: A Cross Sectional Study. Brain Sci. 2020; 10 (10): 693–700. https://doi.org/10.3390/brainsci10100693</mixed-citation><mixed-citation xml:lang="en">May D. S., van Dillen L. R., Earhart G. M. et al. Effects of Subthalamic Nucleus Deep Brain Stimulation and Levodopa on Balance in People with Parkinson's Disease: A Cross Sectional Study. Brain Sci. 2020; 10 (10): 693–700. https://doi.org/10.3390/brainsci10100693</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">St George R. J., Carlson-Kuhta P., Burchiel K. J. et al. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012; 116 (6): 1347–1356. https://doi.org/10.3171/2012.2.JNS 11847</mixed-citation><mixed-citation xml:lang="en">St George R. J., Carlson-Kuhta P., Burchiel K. J. et al. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012; 116 (6): 1347–1356. https://doi.org/10.3171/2012.2.JNS 11847</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yin Z., Bai Y., Zou L. et al. Balance response to levodopa predicts balance improvement after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease. NPJ Parkinsons Dis. 2021; 7 (1): 47–55. https://doi.org/10.1038/s41531-021-00192-9</mixed-citation><mixed-citation xml:lang="en">Yin Z., Bai Y., Zou L. et al. Balance response to levodopa predicts balance improvement after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease. NPJ Parkinsons Dis. 2021; 7 (1): 47–55. https://doi.org/10.1038/s41531-021-00192-9</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Fasano A., Aquino C. C., Krauss J. K. et al. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015; 11 (2): 98–110. https://doi.org/10.1038/nrneurol.2014.252</mixed-citation><mixed-citation xml:lang="en">Fasano A., Aquino C. C., Krauss J. K. et al. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015; 11 (2): 98–110. https://doi.org/10.1038/nrneurol.2014.252</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Li H., Liang S., Yu Y. et al. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease. PLoS One. 2020; 15 (9): e0238936-e0238943. https://doi.org/10.1371/journal.pone.0238936</mixed-citation><mixed-citation xml:lang="en">Li H., Liang S., Yu Y. et al. Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease. PLoS One. 2020; 15 (9): e0238936-e0238943. https://doi.org/10.1371/journal.pone.0238936</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rocchi L., Chiari L., Horak F. B. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73 (3): 267–274. https://doi.org/10.1136/jnnp.73.3.267</mixed-citation><mixed-citation xml:lang="en">Rocchi L., Chiari L., Horak F. B. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002; 73 (3): 267–274. https://doi.org/10.1136/jnnp.73.3.267</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Shivitz N., Koop M. M., Fahimi J. et al. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not. Mov Disord. 2006; 21 (8): 1088–1097. https://doi.org/10.1002/mds.20905</mixed-citation><mixed-citation xml:lang="en">Shivitz N., Koop M. M., Fahimi J. et al. Bilateral subthalamic nucleus deep brain stimulation improves certain aspects of postural control in Parkinson's disease, whereas medication does not. Mov Disord. 2006; 21 (8): 1088–1097. https://doi.org/10.1002/mds.20905</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zaidel A., Bergman H., Ritov Y. et al. Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord. 2010; 25 (14): 2379–2386. https://doi.org/10.1002/mds.23294</mixed-citation><mixed-citation xml:lang="en">Zaidel A., Bergman H., Ritov Y. et al. Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord. 2010; 25 (14): 2379–2386. https://doi.org/10.1002/mds.23294</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Temperli P., Ghika J., Villemure J. G. et al. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology. 2003; 60 (1): 78–81. https://doi.org/10.1212/wnl.60.1.78</mixed-citation><mixed-citation xml:lang="en">Temperli P., Ghika J., Villemure J. G. et al. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology. 2003; 60 (1): 78–81. https://doi.org/10.1212/wnl.60.1.78</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">St George R. J., Nutt J. G., Burchiel K. J. et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010; 75 (14): 1292–1299. https://doi.org/10.1212/WNL.0b013e3181f61329</mixed-citation><mixed-citation xml:lang="en">St George R. J., Nutt J. G., Burchiel K. J. et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010; 75 (14): 1292–1299. https://doi.org/10.1212/WNL.0b013e3181f61329</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Brandmeir N. J., Brandmeir C. L., Carr D. et al. Deep Brain Stimulation for Parkinson Disease Does not Worsen or Improve Postural Instability: A Prospective Cohort Trial. Neurosurgery. 2018; 83 (6): 1173–1182. https://doi.org/10.1093/neuros/nyx602</mixed-citation><mixed-citation xml:lang="en">Brandmeir N. J., Brandmeir C. L., Carr D. et al. Deep Brain Stimulation for Parkinson Disease Does not Worsen or Improve Postural Instability: A Prospective Cohort Trial. Neurosurgery. 2018; 83 (6): 1173–1182. https://doi.org/10.1093/neuros/nyx602</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Maurer C., Mergner T., Xie J. et al. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain. 2003; 126 (5): 1146–1163. https://doi.org/10.1093/brain/awg100</mixed-citation><mixed-citation xml:lang="en">Maurer C., Mergner T., Xie J. et al. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain. 2003; 126 (5): 1146–1163. https://doi.org/10.1093/brain/awg100</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
